exRNAdisease

Entry Detail

---



General Information

Database ID: exR0261560 RNA Name: hsa-miR-124-3p RNA Type: miRNA Chromosome: chr8 Starnd: + Coordinate: Start Site(bp): 64379210 End Site(bp): 64379231 External Links: hsa-miR-124-3p

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE134266 Description: Deep sequencing identified serum extracellular vesicle delivered miR-181a-5p as an indicator for bone-metastatic prostate cancer (microarray) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Bone Metastatic Prostate Cancer Case Sample: Bone Metastatic Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 8 Number of Control: 9 Number of Samples: 17

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand CDH1 chr16 68737292 68835541 + MDK chr11 46380756 46383837 + TRAPPC10 chr21 44012309 44106552 + COL12A1 chr6 75084326 75206053 - RANBP10 chr16 67723070 67806652 - TSEN54 chr17 75516060 75524735 + ZCCHC24 chr10 79382325 79445624 - ASF1B chr19 14119512 14136613 - RPS10-NUDT3 chr6 34284887 34426071 - JAG1 chr20 10637684 10673999 - RPS6KA3 chrX 20149911 20267519 - CTDSP1 chr2 218398256 218405941 + NUDT3 chr6 34279679 34392669 - FAM102A chr9 127940582 127980989 - MMS22L chr6 97142161 97283217 - EPHB4 chr7 100802565 100827523 - ANGPTL2 chr9 127087348 127122635 - BLOC1S5-TXNDC5 chr6 7881522 8064364 - PAPSS2 chr10 87659613 87747705 + C20orf27 chr20 3753508 3768387 - MOB4 chr2 197515571 197553699 + SCAMP2 chr15 74843730 74873365 - CDKN2A chr9 21967753 21995301 - G3BP2 chr4 75642782 75724525 - ZSCAN22 chr19 58326994 58342332 + ANKRD52 chr12 56237807 56258384 - NFAT5 chr16 69565094 69704666 + CREB3L2 chr7 137874979 138002086 - CLASP1 chr2 121337776 121649587 - MLLT1 chr19 6210381 6279975 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001186 chr21 35475133 35475818 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC008040.1 chr3 169939353 169966734 - AC069281.2 chr7 100572232 100578700 - AC084082.1 chr8 66112667 66126632 + FGD5-AS1 chr3 14920347 14948424 - KCNQ1OT1 chr11 2608328 2699994 - LINC00240 chr6 26956932 27059749 + MALAT1 chr11 65497688 65506516 + NEAT1 chr11 65422774 65445540 + SNHG16 chr17 76557764 76565348 + TMEM147-AS1 chr19 35540738 35546029 - XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE134266 Sample Source: Blood Source Fraction: Extracellular Vesicle Platform: GPL25134 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2519 Sample treatment protocol: The blood was centrifuged at 2000 g for 10 min at 4 °C to extract the serum. The serum EV was extracted using Total Exosome Isolation Kit (from serum, Thermo fisher scientific). RNA Extract protocol: Exosome Purification and RNA Isolation Kit (Norgen Biotek) was employed to purify EV and extract total RNA in EV consequentially. RNA library preparation protocol: Sample tag and reagents are included in the hybrid need Agilent's micrornas Complete Labeling and Hyb Kit (p/n 5190-0456).

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA